Parmax Pharma Ltd (PARMAX) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 30.8% of Parmax Pharma Ltd, FIIs -, DIIs -, government - and the public 69.2%, across 2,273 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% | 30.8% |
| Public | 69.2% | 69.2% | 69.2% | 69.21% | 69.21% | 69.2% | 69.21% | 69.2% |
| No. of Shareholders | 2,246 | 2,334 | 2,356 | 2,377 | 2,399 | 2,393 | 2,388 | 2,273 |